×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FOLD – amicus therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FOLD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
8/5
04:01 am
fold
Amicus Therapeutics, Inc. (FOLD) CEO Bradley Campbell on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]
High
Report
Amicus Therapeutics, Inc. (FOLD) CEO Bradley Campbell on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]
8/4
07:00 am
fold
Amicus Therapeutics Announces Second Quarter 2022 Financial Results
Medium
Report
Amicus Therapeutics Announces Second Quarter 2022 Financial Results
7/26
07:00 am
fold
Amicus Therapeutics to Announce Second Quarter 2022 Financial Results on August 4, 2022
Low
Report
Amicus Therapeutics to Announce Second Quarter 2022 Financial Results on August 4, 2022
6/8
07:15 am
fold
Amicus Therapeutics To Present At The Goldman Sachs 43rd Annual Global Healthcare Conference [TheStreet.com]
Low
Report
Amicus Therapeutics To Present At The Goldman Sachs 43rd Annual Global Healthcare Conference [TheStreet.com]
6/8
07:00 am
fold
Amicus Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
Low
Report
Amicus Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
6/6
10:00 am
fold
CISCRP, DIA Collaborate on 5K Run & Walk Event to Recognize All Clinical Trial Volunteers
Low
Report
CISCRP, DIA Collaborate on 5K Run & Walk Event to Recognize All Clinical Trial Volunteers
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
8/9
06:02 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Aug 05 Filed by: Quimi Daphne
Low
Report
Form 4 AMICUS THERAPEUTICS, For: Aug 05 Filed by: Quimi Daphne
8/9
06:02 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Aug 05 Filed by: Clark David Michael
Low
Report
Form 4 AMICUS THERAPEUTICS, For: Aug 05 Filed by: Clark David Michael
8/4
04:09 pm
fold
Form 10-Q AMICUS THERAPEUTICS, For: Jun 30
High
Report
Form 10-Q AMICUS THERAPEUTICS, For: Jun 30
8/4
07:02 am
fold
Form 8-K AMICUS THERAPEUTICS, For: Aug 04
Medium
Report
Form 8-K AMICUS THERAPEUTICS, For: Aug 04
8/3
08:39 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Aug 01 Filed by: Rosenberg Ellen
Medium
Report
Form 4 AMICUS THERAPEUTICS, For: Aug 01 Filed by: Rosenberg Ellen
8/3
08:38 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Aug 01 Filed by: Crowley John F
Medium
Report
Form 4 AMICUS THERAPEUTICS, For: Aug 01 Filed by: Crowley John F
8/3
08:35 pm
fold
Form 4 AMICUS THERAPEUTICS, For: Aug 01 Filed by: Campbell Bradley L
Medium
Report
Form 4 AMICUS THERAPEUTICS, For: Aug 01 Filed by: Campbell Bradley L
8/1
05:11 pm
fold
Form 8-K AMICUS THERAPEUTICS, For: Aug 01
Low
Report
Form 8-K AMICUS THERAPEUTICS, For: Aug 01
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
4/24
Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020
4.3%
7/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was given a new $18.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 4.4%
3/24 Form 4 AMICUS THERAPEUTICS, For: Mar 20 Filed by: Crowley John F 4.4%
10/3 Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) A Volatile Stock? [Yahoo! Finance News] 4.8%
1/14 Form 4 AMICUS THERAPEUTICS, For: Jan 10 Filed by: Barth Jay 5.4%
6/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.8%
2/4 Form 4 AMICUS THERAPEUTICS, For: Jan 31 Filed by: Crowley John F 6.5%
3/9 Form 4 AMICUS THERAPEUTICS, For: Mar 05 Filed by: Campbell Bradley L 6.9%
2/4 Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock, up previously from $19.00. 7.0%
4/2 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.5%
7/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was given a new $18.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 4.4%
3/24 Form 4 AMICUS THERAPEUTICS, For: Mar 20 Filed by: Crowley John F 4.4%
10/3 Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) A Volatile Stock? [Yahoo! Finance News] 4.8%
1/14 Form 4 AMICUS THERAPEUTICS, For: Jan 10 Filed by: Barth Jay 5.4%
6/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.8%
2/4 Form 4 AMICUS THERAPEUTICS, For: Jan 31 Filed by: Crowley John F 6.5%
3/9 Form 4 AMICUS THERAPEUTICS, For: Mar 05 Filed by: Campbell Bradley L 6.9%
2/4 Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock, up previously from $19.00. 7.0%
4/2 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.5%
TOP News Decliners
8/2
Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina
-9.0%
10/3 Amicus snaps back on positive data from Pompe Disease study of AT-GAA [Seeking Alpha] -10.0%
1/13 Form 8-K AMICUS THERAPEUTICS, For: Jan 13 -5.7%
1/18 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -6.0%
7/4 Why Amicus Therapeutics' Stock Perked Up in June [The Motley Fool] -6.2%
8/8 Q2/2019 6/30/2019 EPS -0.360 ZacksConsensus -0.340 ActVsEst (0.020) - Miss -6.7%
12/4 Form 4 AMICUS THERAPEUTICS, For: Dec 02 Filed by: Crowley John F -6.8%
5/29 Amicus Therapeutics Announces Public Offering of Common Stock -7.2%
8/8 Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
3/2 Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates -8.4%
10/3 Amicus snaps back on positive data from Pompe Disease study of AT-GAA [Seeking Alpha] -10.0%
1/13 Form 8-K AMICUS THERAPEUTICS, For: Jan 13 -5.7%
1/18 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -6.0%
7/4 Why Amicus Therapeutics' Stock Perked Up in June [The Motley Fool] -6.2%
8/8 Q2/2019 6/30/2019 EPS -0.360 ZacksConsensus -0.340 ActVsEst (0.020) - Miss -6.7%
12/4 Form 4 AMICUS THERAPEUTICS, For: Dec 02 Filed by: Crowley John F -6.8%
5/29 Amicus Therapeutics Announces Public Offering of Common Stock -7.2%
8/8 Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
3/2 Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates -8.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: